As a Crohn’s and Colitis Canada supporter, we wanted to inform you that Mina Mawani is no longer with the organization. During her five years as President and CEO of Crohn’s and Colitis Canada, Mina has been instrumental in advancing our five-year strategic plan, delivering important research initiatives such as the GEM Project, PACE, various patient programs and in building relationships across our community. Please join us in thanking Mina for her many contributions and wishing her much success for the future.
This year has been unprecedented as we adjust to the realities of COVID-19. While a lot has changed in 2020, one thing remains very clear: our promise to find the cures and to improve the quality of life for everyone affected by these devastating diseases. The work we do is critical to the IBD research landscape in Canada and in helping those living with Crohn’s or colitis. We thank you for standing by us and supporting our important mission.
We are beginning the search for our next leader. Until this process is complete, Susan Cowan is stepping down from her role as a board director to become the interim CEO of Crohn’s and Colitis Canada. Susan is a senior executive with over 20 years experience in finance, risk management and capital markets. She is a respected leader, both within the workplace and in the wider business community.
Both Susan and I are personally affected by Crohn’s and colitis in our family lives. Like you, we share a deep commitment to make things better for everyone affected by these unpredictable diseases and to the success of this organization.
Thank you for your continued support. We are very grateful for all that you do for the Crohn’s and colitis community. We look forward to continuing our partnerships and collaborations.
Sincerely,
Mark Whitmore
Board Chair
Crohn's and Colitis Canada
Susan Cowan
Chief Executive Officer
Crohn's and Colitis Canada